AUG 18, 2026 · PHASE 1 TRIAL
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
ClinicalTrials.gov
Phase 1 study registration with no posted results; designed to evaluate PK similarity and safety of a biosimilar candidate versus reference comparator in early-stage oncology patients.
Reported
Planned enrollment174
Study phasePhase 1
Primary outcome measure 1AUC0-21d from time 0 to 21 days after 1st d…